Literature DB >> 22447140

Effect of triptolide on estradiol release from cultured rat granulosa cells.

Juan Zhang1, Li Liu, Xianmin Mu, Zhenzhou Jiang, Luyong Zhang.   

Abstract

Triptolide, a major active component of Tripterygium wilfordii Hook F (TWHF), is known to have multiple pharmacological activities. However, studies have also shown that triptolide is highly toxic to the reproductive system by disrupting normal androgen and estrogen signaling. In the present study, we investigated the effect of triptolide (5, 10, or 20 nM for 24 h) on estradiol production by rat granulosa cells. Triptolide inhibited basal and human chorionic gonadotropin (HCG)- or 8-bromo-cAMP-stimulated estradiol production as revealed by RIA assay. Furthermore, the HCG-evoked increase in cellular cAMP content was also inhibited by triptolide, indicating that disruption of the cAMP/PKA signaling pathway may mediate the deleterious effects of triptolide on steroid hormone regulation. In addition, (3)H(2)O tests showed that aromatase activity was significantly inhibited by triptolide in granulosa cells. Western blot and quantitative real-time PCR (qRT-PCR) assays further revealed that triptolide decreased protein and mRNA expression of aromatase in granulosa cells. Moreover, mRNA expression of luteinizing hormone receptor (LHR) was induced by triptolide also using qRT-PCR method. In contrast, cell viability tests using Cell Counting Kit-8 (CCK-8) and 3-(4,5-dimethyl-thiazol-2-yl)-2,5- diphenyl-tetrazolium bromide (MTT) method indicated that triptolide did not cause measurable cell death at doses that suppressed steroidogenesis. The reproductive toxicity of triptolide may be mainly caused by disruption of cAMP/PKA-mediated expression of estrogen synthesis enzymes, leading to reduced estradiol synthesis and reproductive dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447140     DOI: 10.1507/endocrj.ej11-0407

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

1.  Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response.

Authors:  Yu Wang; Su-Han Guo; Xue-Jun Shang; Li-Sha Yu; Jian-Wei Zhu; Ang Zhao; Yan-Fen Zhou; Guo-Hua An; Qi Zhang; Bo Ma
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

2.  Triptolide protects against white matter injury induced by chronic cerebral hypoperfusion in mice.

Authors:  Yu-Shan Wan; Yi You; Qian-Yun Ding; Yi-Xin Xu; Han Chen; Rong-Rong Wang; Yu-Wen Huang; Zhong Chen; Wei-Wei Hu; Lei Jiang
Journal:  Acta Pharmacol Sin       Date:  2021-04-06       Impact factor: 6.150

3.  In Vitro Proliferation and Anti-Apoptosis of the Papain-Generated Casein and Soy Protein Hydrolysates towards Osteoblastic Cells (hFOB1.19).

Authors:  Xiao-Wen Pan; Xin-Huai Zhao
Journal:  Int J Mol Sci       Date:  2015-06-17       Impact factor: 5.923

4.  The potential of follicle-stimulating hormone peptide-modified triptolide-loaded nanoparticles to induce a mouse model of premature ovarian insufficiency.

Authors:  Xiu-Ying Chen; Wu-Lian Chen; Min Ma; Chao Gu; Xi-Rong Xiao; Bin Li
Journal:  Int J Nanomedicine       Date:  2015-04-07

Review 5.  Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review.

Authors:  Samira Ziaei; Reginald Halaby
Journal:  Avicenna J Phytomed       Date:  2016 Mar-Apr

Review 6.  The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation.

Authors:  Danping Fan; Qingqing Guo; Jiawen Shen; Kang Zheng; Cheng Lu; Ge Zhang; Aiping Lu; Xiaojuan He
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

7.  Rapid induction of clinical remission in SAPHO syndrome using high-dose Tripterygium glycosides: A case report.

Authors:  Liang Gong; Lun Wang; Yihan Cao; Chen Li
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.